Media
How Our Press Support Can Help
We can create a strong working relationship by providing a wide variety of media services:
Set Up Analyst Interviews
Frost & Sullivan industry experts welcome the opportunity to speak with members of the press and provide quotes to support and add credibility to your article.
We are regularly quoted in a variety of global and industry specific publications, including: Associated Press, BBC, Bloomberg News, Boston Globe, Business Week, CBC Business News, CNBC, CNN, Financial Times, Forbes, Los Angeles Times, Market Watch “Dow Jones”, MSNBC, Newsweek, New York Times, Reuters, The Economist, USA Today, Venture Magazine, Wall Street Journal, Washington Post, and many more.
Provide Industry Market Coverage and Bylined Articles
We can provide analytics overviews on the latest technological advancements, trends, challenges and growth opportunities, as well as quotes, charts, and graphic content. We can also confirm and/or get approval for quoted analytics numbers.
We can also provide full articles or comments on virtually any industry, technology, and region. Frost & Sullivan experts regularly author hot topic driven articles available for re-publication. We grant exclusivity of these articles on a first-come, first-serve basis. Our team can add credibility to an article by adding graphic content illustrating the measurements behind the story.
Provide Access to Think Tanks
Each quarter Frost & Sullivan experts host more than 40 interactive think tanks on dynamic hot topics affecting your industry. We encourage media participation during the live Q&A session with our experts. These think tanks can spur potential story ideas and provide more in-depth insight on topics that you cover. The recording and PowerPoint presentation are available following the think tanks.
Industry Event Participation
We can offer you complimentary press passes to our events to support your research/writing process. We can co-market your company’s event by offering our expertise to fill the role as speaker or moderator.
Recent News
The Future of Infectious Disease Treatment: Are You Investing in Next-Gen Therapeutics?
Infectious Disease Treatment Is Evolving – Are You Keeping Up? The global healthcare landscape is undergoing a significant shift, driven by antimicrobial resistance (AMR), emerging pathogens, and biotechnology advancements. Traditional antibiotics and antivirals are...
Disruptive Technologies of 2025: Top 50 Breakthroughs Reshaping Industries
The Top 50 Technologies of 2025 are transforming industries by driving digital transformation, efficiency, and sustainability while unlocking new investment opportunities. Innovations in microelectronics, quantum sensors, biohybrid materials, and AI-driven...
Top 50 Technologies of 2025: Transforming Industries & Driving Strategic Investments
Are You Investing in the Future of Innovation? The rapid pace of technological evolution is accelerating, reshaping industries and forcing businesses to rethink their growth strategies. From AI-driven cybersecurity to quantum sensors, energy-efficient manufacturing,...
The Growing Impact of Nanotechnology in Nutraceuticals
The Growing Impact of Nanotechnology in Nutraceuticals The increasing demand for personalized health solutions is propelling advancements in nutraceutical delivery. Nanotechnology, with its potential to encapsulate bioactive compounds into nanocarriers, is...
Top Manufacturing Technologies Driving the Future of Automotive & Aerospace Industries
The automotive and aerospace manufacturing industries are undergoing a profound transformation fueled by the rapid adoption of electric vehicles (EVs), sustainable aviation fuels (SAFs), and smart manufacturing technologies. As manufacturers strive to meet the growing...
Making Sense of The DeepSeek Moment: A Leap towards Value Creation through AI Sovereignty and Public Sector Innovation
What is the hype about Deepseek? DeepSeek, a Hangzhou-based Chinese AI company, was founded by a quantitative hedge fund company High-Flyer in 2023. The company focuses on AI research and has been building open-source large language models (LLMs) optimized for limited...
15 Years of Technology Disruption: The Evolution of the Top 50 Technologies
For over 15 years, Frost & Sullivan’s Top 50 Technologies Initiative has identified game-changing innovations that redefine industries and create multi-billion-dollar opportunities. From hybrid energy systems and artificial intelligence (AI)-driven automation to...
Transformative Megatrends for 2025: Defining the Future of Business & Innovation
As industries undergo rapid shifts, business leaders are navigating a landscape shaped by artificial intelligence (AI), geopolitical realignments, sustainability imperatives, and evolving digital ecosystems. The pace of AI innovation is accelerating at an...
Top 50 Technologies Shaping the Future of Industries
As industries undergo rapid transformation, emerging technologies are driving significant disruption across key sectors, enabling smarter decisions and fostering sustainable growth. From artificial intelligence (AI) to advanced materials, Frost & Sullivan’s 15th...
Top Emerging Technologies: Revolutionizing Healthcare, Energy, and Manufacturing by 2030
In a fast-evolving technological landscape, ignoring innovation could mean missing out on opportunities that will define the next decade. From healthcare advancements to energy storage breakthroughs and fully autonomous manufacturing, technologies at lower Technology...
Transforming Global Supply Chains with Nearshoring for Agility and Resilience
Shifting to Nearshoring for Supply Chain Success Transforming global supply chains, nearshoring is emerging as a pivotal strategy for overcoming disruptions caused by geopolitical conflicts, raw material shortages, and trade route vulnerabilities. By relocating...
Immune-Oncology Innovations: The Future of Cancer Treatment with ICIs, CAR-T, and CAR-NK Cell Therapies
The landscape of immune-oncology (I-O) is rapidly evolving, driven by groundbreaking innovations in cell therapies and immune checkpoint inhibitors (ICIs). As the leading class of I-O agents, ICIs continue to be a foundational treatment for various cancers, while...
"*" indicates required fields
